Mettler-Toledo International Inc (MTD)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $34.59B
Last updated: Nov 17, 2026 at 11:05 AM ET
Mettler-Toledo International Inc (MTD) Financials: Revenue, Profit and Cash Flow
Mettler-Toledo International reported revenue of $4.03B for the fiscal year ended Dec 31, 2025, up 4.0% from the year before. That year, net income was $869.19M with a net margin of 21.6%, operating cash flow was $955.77M and free cash flow was $848.65M. The quarter ended Sep 30, 2026 had revenue of $1.09B and net income of $245.95M.
Revenue and Margins
The operating margin was 27.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.51B, a compound annual rate of 5.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $4.03B | +4.0% | 59.4% | 27.3% | 21.6% |
| Dec 2024 | $3.87B | +2.2% | 60.1% | 28.6% | 22.3% |
| Dec 2023 | $3.79B | -3.4% | 59.2% | 27.6% | 20.8% |
| Dec 2022 | $3.92B | +5.4% | 58.9% | 28.5% | 22.3% |
| Dec 2021 | $3.72B | +20.5% | 58.4% | 26.6% | 20.7% |
| Dec 2020 | $3.09B | +2.5% | 58.4% | 25.1% | 19.5% |
| Dec 2019 | $3.01B | +2.5% | 57.9% | 23.7% | 18.6% |
| Dec 2018 | $2.94B | -64.1% | 57.4% | 22.6% | 17.5% |
| Dec 2017 | $8.18B | +225.9% | 19.3% | 74.0% | 4.6% |
| Dec 2016 | $2.51B | N/A | 57.3% | 21.2% | 15.3% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 0.7% from the year before. In the quarter ended Sep 2026, net income rose 13.1% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $3.87B | $3.79B | $3.92B | $3.72B | $3.09B | $3.01B | $2.94B | $8.18B | $2.51B |
| Cost of revenue | $1.64B | $1.55B | $1.55B | $1.61B | $1.55B | $1.28B | $1.27B | $1.25B | $1.15B | $1.07B |
| Gross profit | $2.39B | $2.33B | $2.24B | $2.31B | $2.17B | $1.80B | $1.74B | $1.68B | $1.58B | $1.44B |
| Research and development | $199.37M | $189.36M | $185.28M | $177.12M | $169.77M | $140.10M | $143.95M | $141.07M | $128.31M | $119.20M |
| Operating income | $1.10B | $1.11B | $1.05B | $1.12B | $989.50M | $773.53M | $712.63M | $664.56M | $6.05B | $530.89M |
| Net income | $869.19M | $863.14M | $788.78M | $872.50M | $768.99M | $602.74M | $561.11M | $512.61M | $375.97M | $384.37M |
| EBITDA | $1.24B | $1.24B | $1.17B | $1.24B | $1.10B | $886.07M | $807.49M | $771.06M | $6.13B | $601.01M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.03B | $947.13M | $1.13B | $1.03B | $983.22M | $883.74M | $1.05B | $954.53M | $946.75M | $925.95M | $934.99M |
| Gross profit | $654.22M | $650.22M | $555.82M | $675.43M | $609.46M | $579.88M | $525.88M | $639.32M | $572.47M | $565.67M | $548.13M | $551.64M |
| Operating income | $310.13M | $309.02M | $219.33M | $338.76M | $283.93M | $262.15M | $215.77M | $331.55M | $275.70M | $260.59M | $239.44M | $250.64M |
| Net income | $245.95M | $232.90M | $169.45M | $285.76M | $217.49M | $202.35M | $163.59M | $252.30M | $211.52M | $221.81M | $177.51M | $184.79M |
Balance Sheet
As of Dec 2025, total debt of $2.15B exceeded cash and equivalents by $2.09B. Shareholder equity was negative, at -$23.64M, as total liabilities of $3.74B exceeded total assets of $3.71B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.71B | $3.24B | $3.36B | $3.49B | $3.33B | $2.81B | $2.79B | $2.62B | $2.55B | $2.17B |
| Current assets | $1.36B | $1.19B | $1.23B | $1.38B | $1.27B | $1.06B | $1.11B | $1.05B | $148.69M | $896.78M |
| Cash and equivalents | $66.89M | $59.36M | $69.81M | $95.97M | $98.56M | $94.25M | $207.78M | $178.11M | $148.69M | $158.67M |
| Total liabilities | $3.74B | $3.37B | $3.51B | $3.47B | $3.16B | $2.53B | $2.37B | $2.03B | $107.17M | $1.73B |
| Short-term debt | $63.93M | $182.62M | $192.22M | $106.05M | $101.13M | $50.32M | $55.87M | $49.67M | $19.68M | $18.97M |
| Long-term debt | $2.09B | $1.83B | $1.89B | $1.91B | $1.58B | $1.28B | $1.24B | $985.02M | $960.17M | $875.06M |
| Shareholder equity | -$23.64M | -$126.89M | -$149.94M | $24.79M | $171.42M | $282.68M | $420.78M | $590.06M | $547.28M | $434.94M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.70B | $3.67B | $3.67B | $3.71B | $3.52B | $3.40B | $3.23B | $3.24B | $3.32B | $3.25B | $3.28B | $3.36B |
| Total liabilities | $3.62B | $3.66B | $3.71B | $3.74B | $3.77B | $3.66B | $3.42B | $3.37B | $3.47B | $3.40B | $3.44B | $3.51B |
| Cash and equivalents | $52.24M | $51.38M | $60.57M | $66.89M | $69.06M | $61.83M | $64.29M | $59.36M | $71.57M | $70.81M | $70.19M | $69.81M |
| Shareholder equity | $77.66M | $12.82M | -$41.88M | -$23.64M | -$249.20M | -$258.79M | -$181.98M | -$126.89M | -$154.35M | -$152.76M | -$158.72M | -$149.94M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 88.8% of operating cash flow. Share repurchases came to 95.2% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $955.77M | $968.35M | $965.87M | $859.07M | $908.83M | $724.70M | $603.45M | $565.00M | $516.33M | $460.76M |
| Capital expenditures | $107.12M | $103.90M | $105.32M | $121.24M | $107.58M | $92.49M | $97.34M | $142.73M | $127.43M | $123.96M |
| Free cash flow | $848.65M | $864.45M | $860.55M | $737.83M | $801.25M | $632.21M | $506.11M | $422.28M | $388.90M | $336.80M |
| Dividends paid | N/A | N/A | $19.23M | N/A | $20.46M | $26.72M | $47.58M | N/A | $0 | $0 |
| Share repurchases | $807.75M | $850.00M | $900.00M | $1.10B | $1000.00M | $775.00M | $775.00M | $475.00M | $400.00M | $499.99M |
| Investing cash flow | -$193.87M | -$119.46M | -$131.69M | -$139.40M | -$314.11M | -$100.36M | -$99.08M | -$138.94M | -$217.34M | -$231.46M |
| Financing cash flow | -$755.17M | -$855.98M | -$859.59M | -$716.04M | -$590.55M | -$743.91M | -$477.37M | -$388.02M | -$319.53M | -$163.60M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $260.22M | $139.79M | $225.59M | $299.37M | $236.37M | $194.45M | $266.19M | $254.67M | $189.99M | $281.50M | $264.30M | $266.81M |
| Capital expenditures | $27.82M | $17.41M | $41.50M | $24.49M | $23.88M | $17.25M | $41.28M | $21.42M | $17.39M | $32.42M | $20.96M | $28.75M |
| Free cash flow | $232.41M | $122.38M | $184.08M | $274.88M | $212.49M | $177.19M | $224.91M | $233.25M | $172.60M | $249.09M | $243.34M | $238.06M |
Frequently Asked Questions About MTD
What is Mettler-Toledo International's annual revenue?
Mettler-Toledo International reported revenue of $4.03B for the fiscal year ended Dec 31, 2025.
How fast is Mettler-Toledo International's revenue growing?
Revenue was up 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.9%.
Is Mettler-Toledo International profitable?
Yes. Mettler-Toledo International reported net income of $869.19M for the fiscal year ended Dec 31, 2025, with a net margin of 21.6%.
How much free cash flow does MTD generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $955.77M minus capital expenditures of $107.12M produced free cash flow of $848.65M.
How much debt does Mettler-Toledo International have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.09B, short-term debt of $63.93M and cash and equivalents of $66.89M.
MTD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts